ARCHIVES

Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent

This article is from The Cancer Letter archive.

Vol. 39 No. 25 | June 21, 2013

Download PDF Visit The Full Archive

Related Articles

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014

NHLBI Advisers Commit Funding TO NCI’s Women’s Health Trials, Tamoxifen Trial

March 8, 1991

NCI Pushing Ahead With Antismoking Campaign Involving Entire States, Physicians, Even Lawyers

March 27, 1987

Rauscher Responds To Criticism

March 21, 1975

Radiation Therapy Combination Better For Treating Cancer Spread To Brain

May 28, 2004

In Brief: alberts elected To Second Term as NAS President

February 19, 1999